DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fxmb2f/global_ventricular) has announced the addition of the "Global Ventricular Assist Device Market 2011-2015" report to their offering.
One of the key factors contributing to this market growth is worldwide shortage of heart donors. The Global Ventricular Assist Device market has also been witnessing the trend of an increase in mergers and acquisitions. However, availability of alternative treatments could pose a challenge to the growth of this market.
Key vendors dominating this market space include Thoratec Corp., Abiomed Inc., and HeartWare International Inc.
Commenting on the report, an analyst from TechNavio's Healthcare team said; There has been an increase in the number of cardiac centers in the US. As there is a rise in numbers of people affected by various heart diseases the number of cardiac centers is also increasing in the country. Due to the availability of advanced Ventricular Assist Device (VAD) procedures in these new cardiac centers the procedure can be carried out efficiently in the US.
According to the report, the implantation of a VAD takes the load off the ventricle in order to reduce the heart's work, allowing a potential recovery. Due to the long waiting periods and lack of availability of hearts for transplant, VADs have emerged in recent years as a promising intermediate support option or alternative to heart transplant. Thus, the shortage of donor hearts for transplantation is leading to an increase in the adoption of VADs in patients with end-stage heart failure conditions.
Further, the report also discusses that availability of alternative treatments is one of the main challenges adversely affecting the growth of the Global VAD market.
For more information visit http://www.researchandmarkets.com/research/fxmb2f/global_ventricular